Düsseldorf/Mumbai, May 02, 2019 Gerresheimer's Indian plants produce glass vials, ampoules, and bottles that are specially designed for storage of high quality drugs. These are all examples of primary packaging, which means they come into direct contact with their contents. For pharmaceutical applications, therefore they must be manufactured in line with the stringent requirements of the relevant pharmacopeias. After all, the packaging must allow drugs to be stored safely until their use. Gerresheimer is to present its glass packaging solutions at booth D6 at the InnoPack Pharma Confex at Sahara Star Hotel in Mumbai on May 21 and 22.

Gerresheimer has two plants at its site in the Indian city of Kosamba: The recently constructed Gerresheimer plant manufactures vials and ampoules for the pharmaceutical industry using tubular glass, while Neutral Glass makes moulded glass products for pharmaceutical applications and only very recently put a new high-performance furnace into operation.

Quality from the outset: Clean room control at the cold end and GMP 15378 certified manufacturing facilities:

'The upgraded technological features of our new furnace for type I glass has significantly enhanced our quality levels to meet growing demands of pharmaceuticals worldwide' says Khasim Saheb, Managing Director for Primary Packaging Glass in India and SEA. Most importantly, he explains, the glass is considerably more homogeneous, thanks to an improved electrical boosting control during conditioning and processing. The state-of-the-art furnace has higher pull rate, he adds. Along with the construction and technological upgradation on the new furnace, a clean room inspection area was also added at the cold end, also installed on-line camera inspection systems to guarantee a comprehensive examination of the finished products before 'safe packing'. The new plant is certified in accordance with GMP ISO 15378 standards.

Attachments

  • Original document
  • Permalink

Disclaimer

Gerresheimer AG published this content on 02 May 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 May 2019 08:47:08 UTC